World Health Summit – IFPMA Session: Antimicrobial Resistance: Moving from Talk to Action
17 October 2017
10:00 to 18:00
Karl-Marx-Allee 131a 10243 Berlin
This event has now passed. To browse our upcoming events click here.
Held once a year, the WHS has grown into the world’s most prominent forum for addressing global health issues. It brings together key leaders from academia, politics, civil society, and the private sector to address the most pressing health-related challenges on the planet.
IFPMA will host a session on the theme of “Antimicrobial Resistance: Moving from Talk to Action” on 17th October at 16h30.
This workshop will explore how to move the global discourse on combatting antimicrobial resistance (AMR) from a theoretical debate to practical solutions at the regional and national levels. Speakers will be invited to express their views on the following questions:
– What is industry currently doing to combat AMR and where can it most make a difference?
– What are some of the best practice examples of governments’ programs to combat AMR?
– How could the industry and governments better collaborate to find practical solutions?
– What is needed at the country level to facilitate the piloting of new approaches to combat AMR? What would be the characteristics?
Link to WHS Program: https://www.registration-whs.com/Program/WHS2017
o Moderator of the investigative political TV-magazine “Kontraste”, ARD since 2009.
o Moderator and consultant of high-level conferences since many years (i.a. for The German President, Federal Chancellery, Federal Ministries, acatec, BDI, Bitcom, Deutsche Messe).
o TV Host of talkshows and news programmes (rbb, SAT.1, N24).
o Chairwoman of the board of management of “Reporters without Borders”, 2004-2016.
o Middle East Correspondent for Israel, Egypt, Jordan, Iraq and Lebanon, 1994-1999.
Karin Knufmann-Happe has been Director General of Directorate-General 3 for Health Protection, Disease Control and Biomedicine at the German Federal Ministry of Health since 2006. A fully qualified lawyer, she joined the Federal Ministry of Labour and Social Affairs in 1989 and from 1992 to 1995, she was seconded to the European Commission in Brussels where she worked as a national expert in the Pharmaceuticals Unit of Directorate-General III (Industry). Since February 1995, Ms Knufmann-Happe has held various functions at the Federal Ministry of Health and the Federal Ministry of Health and Social Security. In 2005, she was appointed Director General of DirectorateGeneral 5 for Matters relating to Disabled Persons, Social Assistance at the Federal Ministry of Health and Social Security.
Dr Ruediger Krech is the Director for Health Systems and Innovation at the World Health Organization. The cluster of Health Systems and Innovation (HIS) covers WHO’s work in the areas of safe and effective medicines and health technologies, integrated people-centered health services, health workforce, financing and health governance, evidence, information and research. He is the cluster’s focal point for the WHO reform, in particular on issues relating to WHO leadership priorities, governance and management. Before that, Dr Krech was the Director of the Department of Ethics, Equity, Trade and Human Rights at the World Health Organization from 2009 to 2012. In this capacity, he was also responsible for WHO’s work on Social Determinants of Health and Health in All Policies.
Jeremy Knox leads the Wellcome Trust’s expanding policy and advocacy activities on antimicrobial resistance, as a key part of the organisation’s five-year, £175m commitment to support the global response to drug-resistant infections through research and policy activities. He joined Wellcome in July 2017 after eight years working in government at the UK Department for Health. During this time, Jeremy worked in public and global health roles, including a two year secondment from 2014 to 2016 to be deputy head of the small team working on Lord Jim O’Neill’s Review on Antimicrobial Resistance. Having originally studied economics at the University of Nottingham, Jeremy recently completed a master’s degree in Health Policy at Imperial College, London.
Thomas B. Cueni is Director General of IFPMA since 1 February 2017. Prior to joining IFPMA he was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years Thomas Cueni has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. He represented the industry on the EU High Level Pharmaceutical Forum, was Chairman of EFPIA’s Economic and Social Policy Committee and Chairman of the EFPIA Task Force on the EU Commission’s Pharmaceutical Sector Inquiry. Thomas Cueni also represented Interpharma, which he successfully transformed from the association of Swiss Rx companies to the association of pharmaceutical research companies in Switzerland, on the Council of IFPMA. Prior to his appointment with Interpharma, Thomas Cueni had a career as a journalist, inter alia as London correspondent for the “Basler Zeitung” and “Der Bund”, and he served as a Swiss career diplomat with postings in Paris (OECD) and Vienna (IAEA, UNIDO). He studied at the University of Basle, the London School of Economics, and the Geneva Graduate Institute for International Studies, and has Master degrees in economics (University of Basel) and politics (London School of Economics, LSE).